Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-055648
Filing Date
2017-11-02
Accepted
2017-11-02 07:31:25
Documents
41
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tv477888_10q.htm 10-Q 271870
2 EXHIBIT 31.1 tv477888_ex31-1.htm EX-31.1 9234
3 EXHIBIT 31.2 tv477888_ex31-2.htm EX-31.2 9168
4 EXHIBIT 32.1 tv477888_ex32-1.htm EX-32.1 3378
  Complete submission text file 0001144204-17-055648.txt   3230068

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT gnmx-20170930.xml EX-101.INS 930746
6 XBRL TAXONOMY EXTENSION SCHEMA gnmx-20170930.xsd EX-101.SCH 36333
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnmx-20170930_cal.xml EX-101.CAL 20196
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnmx-20170930_def.xml EX-101.DEF 184572
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnmx-20170930_lab.xml EX-101.LAB 205149
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnmx-20170930_pre.xml EX-101.PRE 197323
Mailing Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087
Business Address 435 DEVON PARK DRIVE, SUITE 715 WAYNE PA 19087 610-254-4201
Aevi Genomic Medicine, Inc. (Filer) CIK: 0001138776 (see all company filings)

EIN.: 980217544 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35112 | Film No.: 171170735
SIC: 2836 Biological Products, (No Diagnostic Substances)